Brief: vTv Therapeutics Inc. Q2 operating income USD -8 million
11/08/2023 21:44
Aug 11 (Reuters) - vTv Therapeutics Inc. Q2 operating income USD -8 million. * Q2 operating expenses USD 8 million
Recent news on vTv Therapeutics
See all newsBrief: Vtv Therapeutics Announces FDA Orphan Drug Designation For Hppd In Sickle Cell Disease
vTv Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
vTv Therapeutics Inc expected to post a loss of $1.04 a share - Earnings Preview
vTv Therapeutics Q2 net loss widens on higher trial costs
Brief: VTv Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)